A 1H and 31P NMR study of cis‐Pt(NH3)2 [d(CpGpG)‐N7 (2),N7 (3)] The influence of a 5′‐terminal cytosine, on the structure of the cis‐Pt(NH3)2 [d(GpG)‐N7,N7] instrastrand cross‐link
Open Access
- 3 March 1985
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 147 (2) , 371-379
- https://doi.org/10.1111/j.1432-1033.1985.tb08760.x
Abstract
Proton NMR studies at 300 MHz and 500 MHz have been carried out on the trinucleoside bisphosphate d(CpGpG) and on cis‐Pt(NH3)2[d(CpGpG)‐N7 (2),N7 (3)] [abbreviated as d(CpGpGp) ·cisPt]. For the Pt adduct, 13C and 31P NMR was also used for characterizing the oligonucleotide. d(CpGpG) appears to revert to a B‐DNA‐type single helix at lower temperatures. The relatively small concentration dependence of the proton chemical shifts, in comparison with shifts due to intramolecular stacking effects, indicates that the compound is essentially single‐stranded. In d(CpGpGp) ·cisPt, the first nucleoside, C(1), stacks well on top of the second, G(2), despite the N conformation of the G(2) sugar ring. The platinated GpG part in this trimer adopts largely the same structure as in cis‐Pt(NH3)2[d(GpGpG)‐N7 (1),N7 (2)] [den Hartog, J. H. J., et al. (1982) Nucleic Acids Res. 10, 4715–4730]. Main differences however, are changes in H8 chemical shifts and a 0.6‐ppm downfield shift of the third nucleotide phosphorus, P(3), in d(CpGpGp) ·cisPt with respect to P(2) in d(GpG) ·cisPt. The latter shift change is likely to be induced by a structural alteration, caused by stacking of C(1) on top of G(2). Also, the large chemical shift differences between the two H8 protons in d(NpGpG) ·cisPt fragments is discussed; the deviation from a mirror symmetry of the two guanine bases seems to be the main origin of this effect. The chemical shift changes, observed in the proton and phosphorus NMR chemical shift temperature and chemical shift pH profiles have been explained in terms of stack‐destack equilibria changes.Keywords
This publication has 45 references indexed in Scilit:
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985
- Interaction of platinum compounds with short oligodeoxynucleotides containing guanine and cytosineEuropean Journal of Biochemistry, 1983
- Binding of platinum compounds to nucleic acids with respect to the anti‐tumor activity ofcis‐diamminedichloroplatinum(II) and derivativesRecueil des Travaux Chimiques des Pays-Bas, 1983
- Specific platinum chelation by the guanines of the deoxyhexanucleotide d(T-G-G-C-C-A) upon reaction with cis-[Pt(NH3)2(H2O)2](NO3)2Biochemical and Biophysical Research Communications, 1982
- cis-Diamminedichloroplatinum(II) binds in a unique manner to oligo(dG).oligo(dC) sequences in DNA - a new assay using exonuclease IIIJournal of the American Chemical Society, 1981
- Chelation of cis‐Pt(NH3)2Cl2 by the deoxynucleotide d(C-C-G-G)Recueil des Travaux Chimiques des Pays-Bas, 1981
- Sequence dependent binding of cis-dichlorodiammineplatinum(II) to DNAJournal of the American Chemical Society, 1980
- Selective excitation in Fourier transform nuclear magnetic resonanceJournal of Magnetic Resonance (1969), 1978
- Specific binding of antitumour drug cis-Pt(NH3)2Cl2 to DNA rich in guanine and cytosineNature, 1974
- The reaction of 14C-labelled platinum ethylenediamine dichloride with nucleic acid constituentsChemico-Biological Interactions, 1973